<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200604047655N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-09-29</date_registration>
      <primary_sponsor>Birjand University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effectiveness of Dialectical  Behavioral Therapy and Aromatherapy of Lavender on pregnancy and Childbirth Outcomes</public_title>
      <acronym></acronym>
      <scientific_title>The Effectiveness of Dialectical Behavioral Therapy (DBT)  Training and Aromatherapy Training (Lavender) on Psychological Symptoms of Pregnancy, indicators and Pain Intensity of the First and Second Stages of Childbirth and Competence for the role of Mother after Childbirth of Primiparous Women with Insecure Attachment to the Husband</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-06-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>75</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/49373</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: The randomization method will be performed in a simple, individual random way, using a lottery and assigning each number to a patient. First, determine a total sample size of 75 people, then randomly assign a set of them to group A and set. Assign E to group B and the rest to group C. For example, 25 balls for group A and 25 balls for group B and 25 balls for group C are placed in the lottery container, then the balls are randomly removed from the container without replacement and the created sequence is recorded.</study_design>
      <phase>N/A</phase>
      <hc_freetext>The effect of Lavender and Dialysis Behavior Therapy on delivery outcomes.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: First, during pregnancy, dialysis behavior therapy sessions are presented in 10 sessions of 90 minutes by a doctor of psychology. During childbirth, dilation of 3-4 cm 5 drops in 1 liter of lavender essential oil water is used by inhalation, taking into account the private room for delivery, the administration of essential oil is repeated every 30 minutes. From the beginning of aromatherapy, the mother's pulse and blood pressure are monitored and also at the time of delivery, the duration of the first and second stages of labor, the severity of the mother's pain at the beginning of arrival, before 3-4 cm and 20 minutes after the onset of odor in dilation 5 7.8 at 10-10 cm, second stage of labor, neonatal Apgar score, fetal tachycardia and bradycardia, maternal demand for analgesia, maternal satisfaction with labor during labor, and overt anxiety also assessed by a trained researcher in the intervention group. Intervention 2: Intervention group: This group also started the active phase of labor from lavender essential oil made by Barij Essential Oil Company with a concentration of 1% in the form of 5 drops in 1 liter of water by inhaler with inhaler by considering a private room for labor. And delivery, from dilatation of 3-4 cm to the time of delivery is used and the administration of essential oil will be repeated every 30 minutes. One hour after starting aromatherapy, the mother's pulse and blood pressure are checked and also during delivery, the duration of the first and second stages. Delivery, the severity of maternal pain at arrival, before 3-4 cm and at 20 minutes after the onset of odor in dilatations 5-7 and at 8-10 cm, the second stage of labor, neonatal Apgar score, tachycardia and fetal bradycardia, Maternal demand for analgesia, maternal satisfaction with labor during labor, and overt anxiety will also be measured with the help of a trained researcher in the intervention group. Intervention 3: The intervention group of this group during childbirth with the beginning of the active phase of labor from lavender essential oil made by Barij Essential Oil Pharmaceutical Company with a concentration of 1% in the form of 5 drops in 1 liter of water by inhaler with inhaler taking into account the private room for labor and Delivery is used from dilatation of 3-4 cm until delivery and the administration of essential oil will be repeated every 30 minutes. One hour after starting aromatherapy, the mother's pulse and blood pressure are checked and also during labor, the duration of the first and second stages of labor. Intensity of maternal pain at arrival, before 3-4 cm and at 20 minutes after the onset of odor in dilatations 5-7 and at 8-10 cm, second stage of labor, neonatal Apgar score, tachycardia and fetal bradycardia, rate Maternal demand for analgesia, maternal satisfaction with labor during labor, and overt anxiety will also be measured with the help of a trained researcher in the intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Elham_zameni</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 93, Golchin 3., Ghaffari 18</address>
        <city>Birjand</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9717963741</zip>
        <telephone>+98 56 3244 1097</telephone>
        <email>elham_z2010@YAHOO.COM</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Eham Zameni</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 93, Golchin 3., Ghaffari 18</address>
        <city>Birjand</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9717963741</zip>
        <telephone>+98 56 3244 1097</telephone>
        <email>elham_z2010@YAHOO.COM</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Primiparous Pregnant Women with Insecure Attachment to their Husbands</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Literacy
Single Pregnancy
Voluntary Natural Childbirth and no Medical reason for Cesarean section
Lack of high-risk pregnancies such as Heart Disease, Preeclampsia, Diabetes, threat of Preterm Delivery ...
Failure to participate in psychological Interventions in the last 6 Months Lack of Experience of Traumatic and Stressful Events in the last 6 Months
Do not take Psychological Drugs
No Allergies to Lavender and no Olfactory Problems</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: First, during pregnancy, dialysis behavior therapy sessions are presented in 10 sessions of 90 minutes by a doctor of psychology. During childbirth, dilation of 3-4 cm 5 drops in 1 liter of lavender essential oil water is used by inhalation, taking into account the private room for delivery, the administration of essential oil is repeated every 30 minutes. From the beginning of aromatherapy, the mother's pulse and blood pressure are monitored and also at the time of delivery, the duration of the first and second stages of labor, the severity of the mother's pain at the beginning of arrival, before 3-4 cm and 20 minutes after the onset of odor in dilation 5 7.8 at 10-10 cm, second stage of labor, neonatal Apgar score, fetal tachycardia and bradycardia, maternal demand for analgesia, maternal satisfaction with labor during labor, and overt anxiety also assessed by a trained researcher in the intervention group.</i_keyword>
      <i_keyword>Intervention group: This group also started the active phase of labor from lavender essential oil made by Barij Essential Oil Company with a concentration of 1% in the form of 5 drops in 1 liter of water by inhaler with inhaler by considering a private room for labor. And delivery, from dilatation of 3-4 cm to the time of delivery is used and the administration of essential oil will be repeated every 30 minutes. One hour after starting aromatherapy, the mother's pulse and blood pressure are checked and also during delivery, the duration of the first and second stages. Delivery, the severity of maternal pain at arrival, before 3-4 cm and at 20 minutes after the onset of odor in dilatations 5-7 and at 8-10 cm, the second stage of labor, neonatal Apgar score, tachycardia and fetal bradycardia, Maternal demand for analgesia, maternal satisfaction with labor during labor, and overt anxiety will also be measured with the help of a trained researcher in the intervention group.</i_keyword>
      <i_keyword>The intervention group of this group during childbirth with the beginning of the active phase of labor from lavender essential oil made by Barij Essential Oil Pharmaceutical Company with a concentration of 1% in the form of 5 drops in 1 liter of water by inhaler with inhaler taking into account the private room for labor and Delivery is used from dilatation of 3-4 cm until delivery and the administration of essential oil will be repeated every 30 minutes. One hour after starting aromatherapy, the mother's pulse and blood pressure are checked and also during labor, the duration of the first and second stages of labor. Intensity of maternal pain at arrival, before 3-4 cm and at 20 minutes after the onset of odor in dilatations 5-7 and at 8-10 cm, second stage of labor, neonatal Apgar score, tachycardia and fetal bradycardia, rate Maternal demand for analgesia, maternal satisfaction with labor during labor, and overt anxiety will also be measured with the help of a trained researcher in the intervention group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pregnancy depression. Timepoint: At the beginning of the Study and 35 Days after the start of the intervention. Method of measurement: Beck Depression Inventory.</prim_outcome>
      <prim_outcome>Pregnancy anxiety. Timepoint: At the beginning of the Study and 35 Days after the start of the intervention. Method of measurement: Wendenberg Pregnancy Anxiety Questionnaire.</prim_outcome>
      <prim_outcome>Maternal attachment to the fetus. Timepoint: At the beginning of the Study and 35 Days after the start of the intervention. Method of measurement: Maternal attachment questionnaire to Cranley fetus.</prim_outcome>
      <prim_outcome>Attachment to spouse. Timepoint: At the beginning of the Study and 35 Days after the start of the intervention. Method of measurement: Attachment Questionnaire to Fraley's wife, Waller and Brennan.</prim_outcome>
      <prim_outcome>Obvious anxiety score in the Spielberger questionnaire. Timepoint: At the beginning of the study and 35 days after the intervention and during labor and two weeks after delivery. Method of measurement: Spielberger Obvious Anxiety Questionnaire.</prim_outcome>
      <prim_outcome>Patience score in Khormai, Farmani and Soltani questionnaires. Timepoint: At the beginning of the study and 35 days after the intervention and two weeks after delivery. Method of measurement: Questionnaire of Patience of Date, Command and Soltani.</prim_outcome>
      <prim_outcome>Fear of childbirth score in Harman questionnaire. Timepoint: At the beginning of the study and 35 days after the start of the intervention. Method of measurement: Harman Maternity Fear Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Postpartum Depression Score from the Edinburgh Questionnaire. Timepoint: Two weeks after delivery. Method of measurement: Edinburgh Postpartum Depression Inventory.</sec_outcome>
      <sec_outcome>Parental Competency Score from the Wallston-Gibbord Questionnaire. Timepoint: Two weeks after delivery. Method of measurement: Walston-Gibbord Parental Competency Score Questionnaire.</sec_outcome>
      <sec_outcome>Check the duration of labor. Timepoint: The active phase of the first stage of dilatation The duration of labor will be measured twice during 5-7 and 8-10 cm dilatations of the cervix. The second phase of labor is from dilatation of 10 cm of the cervix until the fetus leaves. Method of measurement: Through vaginal examinations.</sec_outcome>
      <sec_outcome>Evaluation of labor pain intensity. Timepoint: Evaluation of labor pain intensity before active phase and in the first and second stage of labor. Method of measurement: McGill Pain Pain Ruler.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Birjand University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-06-14</approval_date>
        <contact_name>Ethics committee of Birjand University of Medical Sciences</contact_name>
        <contact_address>No. 93, Golchin 3., Ghaffari 18 Birjand South Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
